Stage 3 Draft Recommendations Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup March 18, 2014.

Slides:



Advertisements
Similar presentations
Longitudinal Coordination of Care LTPAC SWG Monday August 5, 2013.
Advertisements

Quality Measures Vendor Tiger Team December 13, 2013.
Understanding Meaningful Use Presented by: Allison Bryan MS, CHES December 7, 2012 Purdue Research Foundation 2012 Review of Stage 1 and Stage 2.
DRAFT Stage 3 Update Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup August 16, 2013.
VISION FOR MEANINGFUL USE. 2 Meaningful Use Workgroup Co-Chairs: Paul Tang, Palo Alto Medical Foundation Farzad Mostashari, New York City Health Department.
HIT Policy Committee Meaningful Use Workgroup Update Paul Tang Palo Alto Medical Foundation George Hripcsak Columbia University December 15, 2009.
Meaningful Use Workgroup Stage 3 Recommendations Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co-Chair.
Meaningful Use Stage 2 Proposed Rule
Meeting Stage 1 Meaningful Use Criterion Carlos A. Leyva, Esq. Digital Business Law Group, P.A.
HIT Policy Committee Meaningful Use Workgroup Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co- Chair October 20,
Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup December 2, 2013.
Interoperability and Health Information Exchange Workgroup April 17, 2015 Micky Tripathi, chair Chris Lehmann, co-chair.
Proposed Meaningful Use Criteria for Stage 2 and 3 John D. Halamka.
HIT Policy Committee Meaningful Use Workgroup Presentation Paul Tang, Chair Palo Alto Medical Foundation George Hripcsak. Co-Chair Columbia University.
HIT Policy Committee Meaningful Use Workgroup Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co- Chair December 13,
MEANINGFUL USE UPDATE 2014 Mark Huang, M.D. Chief Medical Information Officer Rehabilitation Institute of Chicago Associate Professor Department of PM.
Medicare & Medicaid EHR Incentive Programs HIT Policy Committee June 5, 2013.
Medicare & Medicaid EHR Incentive Programs
August 12, Meaningful Use *** UDOH Informatics Brown Bag Robert T Rolfs, MD, MPH.
Moderator Kevin Larsen, MD Medical Director, Meaningful Use Office of the National Coordinator for Health Information Technology Washington, D.C. Using.
Stage 3 Draft Recommendations Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup February 4, 2014.
A First Look at Meaningful Use Stage 2 John D. Halamka MD.
Meaningful Use Stage 2 Esthee Van Staden September 2014.
Meaningful Use Measures. Reporting Time Periods Reporting Period for 1 st year of MU (Stage 1) 90 consecutive days within the calendar year Reporting.
Saeed A. Khan MD, MBA, FACP © CureMD Healthcare ACOs and Requirements for Reporting Quality Measures Meaningful Use Are you still missing out? © CureMD.
Series 1: Meaningful Use for Behavioral Health Providers From the CIHS Video Series “Ten Minutes at a Time” Module 2: The Role of the Certified Complete.
Stage 3 Update Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup January 16, 2014.
Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup April 10, 2014.
DRAFT Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup October 28, 2013.
NWH TRANSITION OF CARE DOCUMENT FOR MU STAGE 2 JUNE 6, 2014.
Meaningful Use Workgroup Subgroup 2 - Engaging Patients and Families June 17, 2013 Christine Bechtel, Subgroup Chair Paul Tang, MU WG Chair 1.
Prepared by: Health Technology Services Regional Extension Center A division of Mountain-Pacific Quality Health.
A First Look at Meaningful Use Stage 2 John D. Halamka MD.
Stage 3 Draft Recommendations Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup February 11, 2014.
Medicaid EHR Incentive Program For Eligible Professionals Overview of the Proposed 2015 Modification Rule Kim Davis-Allen Outreach Coordinator
Affordable Healthcare IT Solutions. MU RX Compliance with Meaningful Use Stage 2.
Stage 3 Draft Recommendations Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup March 11, 2014.
HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,
Clinical Documentation Hearing Recommendations Meaningful Use and Certification and Adoption Workgroups Paul Tang, MU Workgroup Chair Larry Wolf, C&A Workgroup.
Larry Wolf, chair Marc Probst, co-chair Certification / Adoption Workgroup March 19, 2014.
HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,
Component 11: Configuring EHRs Unit 2: Meaningful Use of the Electronic Health Record (EHR) Lecture 1 This material was developed by Oregon Health & Science.
1 Meaningful Use Stage 2 The Value of Performance Benchmarking.
HIT Policy Committee Meaningful Use Workgroup Presentation to HIT Policy Committee Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia.
Meaningful Use Workgroup Population and Public Health – Subgroup 4 Art Davidson, Chair September 11, 2012.
HITPC – Meaningful Use Workgroup Care Coordination – Subgroup 3 Stage 3 Planning July 27, 2012.
DRAFT Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup October 24, 2013.
HIT Policy Committee Adoption/Certification Workgroup Comments on NPRM, IFR Paul Egerman, Co-Chair Retired Marc Probst, Co-Chair Intermountain Healthcare.
Recommendations to the HIT Policy Committee on ONC Standards and Certification NPRM May 2, 2012 Certification and Adoption Workgroup Marc Probst, Intermountain.
HIT Policy Committee Meaningful Use Workgroup Paul Tang, Chair George Hripcsak, Co-Chair June 25, 2010.
HIT Policy Committee Meaningful Use Workgroup Presentation to HIT Standards Committee Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia.
Stage 3 Update Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup January 28, 2014.
HIT Policy Committee Meaningful Use Workgroup Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co- Chair December 13,
HIT Policy Committee Stage 2 Recommendations Presentation to HIT Standards Committee June 22, 2011.
HIT Standards Committee Meaningful Use Workgroup Presentation to HIT Policy Committee on July 16, 2009 As Presented by:Paul Tang, Chair Palo Alto Medical.
Component 11/Unit 2a Meaningful Use of the Electronic Health Record (EHR)
Information Exchange Workgroup Recommendations to HIT Policy Committee October 3, 2012 Micky Tripathi, Larry Garber.
Meaningful Use: Stage 2 Changes An overall simplification of the program aligned to the overarching goals of sustainability as discussed in the Stage.
HIT Policy Committee Meaningful Use Workgroup Update Paul Tang Palo Alto Medical Foundation George Hripcsak Columbia University January 13, 2010.
HIT Policy Committee Meaningful Use Workgroup Presentation to HIT Standards Committee Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia.
What Lies Ahead for ONC Meaningful Use and Beyond Farzad Mostashari, MD ScM National Coordinator for Health Information Technology.
Stage 3 Draft Recommendations Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup March 11, 2014.
HIT Standards Committee Meaningful Use Workgroup Update Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co- Chair.
HIT Policy Committee Meaningful Use Workgroup Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co- Chair October 27,
Configuring axiUm for Meaningful Use
Meaningful Use Workgroup June 24, 2013 Paul Tang, chair George Hripcsak, co-chair 1.
Meaningful Use Workgroup Subgroup 2 - Engaging Patients and Families Christine Bechtel, Subgroup Chair Paul Tang, MU WG Chair July 2,
David W. Bates, MD, MSc Chief Quality Officer, Brigham and Women’s Hospital Member, HIT Policy Committee President-elect, ISQua Medinfo, 2013.
2017 Modified Stage 2 Meaningful Use Objectives Overview Massachusetts Medicaid EHR Incentive Program September 19 & 20, 2017 September 19,
Presentation transcript:

Stage 3 Draft Recommendations Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup March 18, 2014

Meaningful Use Workgroup Members Chairs Paul Tang, Chair, Palo Alto Medical Center George Hripcsak, Co-Chair, Columbia University Members David Bates, Brigham & Women’s Hospital* Christine Bechtel, National Partnership for Women & Families * Neil Calman, The Institute for Family Health Art Davidson, Denver Public Health Department * Paul Egerman, Software Entrepreneur Marty Fattig, Nemaha County Hospital (NCHNET) Leslie Kelly Hall, Healthwise David Lansky, Pacific Business Group on Health Deven McGraw, Center for Democracy & Technology Marc Overhage, Siemens Healthcare Patricia Sengstack, Bon Secours Health Systems Charlene Underwood, Siemens * Michael H. Zaroukian, Sparrow Health System Amy Zimmerman, Rhode Island Department of Health and Human Services Federal Ex-Officios Joe Francis, MD, Veterans Administration Marty Rice, HRSA Greg Pace, Social Security Administration Robert Tagalicod, CMS/HHS 1 * Subgroup Leads

Agenda HITPC feedback Revisions Listening Session 2

HITPC Feedback Recommendations approved Several HITPC members had concerns about provider burden – Wait for attestation experience from stage 2 before proceeding with recommendations on stage 3 Others felt that the recommendations did not go far enough to enable the use of HIT to improve outcomes – Need to leverage technology to enable interoperability, enable longitudinal care, and capture and manage information to allow people to be fully engaged in their care – Registries, quality measurement, and longitudinal care management are important domains that some members felt should be advanced even further The recommendations start a process of information gathering and were approved under this spirit 3

Improving quality of care and safety: Clinical decision support (CDS) 4 Use of CDS to Improve Quality of Care and Safety Core: EP/EH/CAH use of multiple CDS interventions that apply to CQMs in at least 4 of the 6 NQS priorities Recommended intervention areas: 1.Preventive care 2.Chronic disease condition management 3.Appropriateness of lab/rad orders 4.Advanced medication-related decision support 5.Improving problem, meds, allergy lists 6.Drug-drug /drug-allergy interaction checks Red: Changes from stage 2 Blue: Newly introduced Bright Red: edits for clarity Certification criteria: 1.Ability to track “actionable” (i.e., suggested action is embedded in the alert) CDS interventions and user responses actions in response to interventions 2.Perform age-appropriate maximum daily-dose weight based calculation Focus AreaTypeProvider use effortStandards MaturityDevelopment  CDS  Population management  Care coordination Primary care Specialty (selectively) MediumEmerging High

Improving quality of care and safety: Unique device identifier (UDI) 5 Recording FDA UDI to Improve Quality of Care and Safety NEW Menu: Eligible Professionals and Eligible Hospitals record the FDA Unique Device Identifier (UDI) when new device is implanted in a patient patients have devices implanted for each newly implanted device Threshold: High Focus AreaTypeProvider use effortStandards MaturityDevelopment Primary Care Specialty (selectively) LowEmergingMedium Red: Changes from stage 2 Blue: Newly introduced

6 Reducing health disparities: Demographics/patient information Patient Information Captured and Used to Reduce Health Disparities Certification criteria to achieve goals: – Ability to capture patient preferred method of communication – Ability to capture occupation and industry codes – Ability to capture sexual orientation, gender identity (SOGI) – Ability to capture disability status Communication preferences will be applied to visit summary, reminders, and patient education Discussion: Consider using HHS Demographic Data Collection standards and SOGI questions and review the upcoming Institute of Medicine report on social determinants of health Focus AreaTypeProvider use effortStandards MaturityDevelopment  CDS  Patient engagement Primary Care Specialty (selectively) MediumEmergingHigh Red: Changes from stage 2 Blue: Newly introduced Bright Red: edits for clarity

Engaging patients and families in their care: View, download, transmit 7 Access to health Information to Engage Patients and Families in their Care EPs/EHs provide patients with the ability to view online, download, and transmit (VDT) their health information within 24 hours if generated during the course of a visit Threshold for availability: High Threshold for use: low – Labs or other types of information not generated within the course of the visit available to patients within four (4) business days of availability Add family history to data available through VDT Discussion: For EHs, the information available within 24 hours is the same as in stage 2 (which was at 36 hours) Focus AreaTypeProvider use effortStandards MaturityDevelopment  Patient engagement  Care coordination Primary Care Specialty HighEmergingMedium Red: Changes from stage 2 Blue: Newly introduced

Engaging patients and families in their care: Secure messaging 8 Functionality Needed to Achieve Goals No Change in objective Core: Eligible Professionals Patients use secure electronic messaging to communicate with EPs on clinical matters. Threshold: Low (e.g. 5% of patients send secure messages) Certification criteria: – Capability to indicate whether the patient is expecting a response to a message they initiate – Capability to track the thread of responses to a patient-generated message (e.g., no response, secure message reply, telephone reply) Focus AreaTypeProvider use effortStandards MaturityDevelopment  Patient engagement Primary Care Specialty MediumApprovedHigh (tracking) Red: Changes from stage 2 Blue: Newly introduced

Summary of care may (at the discretion of the provider organization) include, as relevant: – A narrative (synopsis, expectations, results of a consult) [required for all transitions] – Overarching patient goals and/or problem- specific goals – Patient instructions (interventions for care) – Information about known care team members Improving care coordination: Summary of care 9 A Summary of Care is Provided at Transitions to Improve Care Coordination EPs/EHs/CAHs provide a summary of care record during transitions of care Threshold: No Change Types of transitions: – Transfers of care from one site of care to another (e.g.. Hospital to: PCP, hospital, SNF, HHA, home, etc) – Consult (referral) request (e.g., PCP to Specialist; PCP, SNF to ED) [pertains to EPs only] – Consult result note (e.g. consult note, ER note) Focus AreaTypeProvider use effortStandards MaturityDevelopment  Care Coordination Primary Care Specialty HighAdoptedHigh Red: Changes from stage 2 Blue: Newly introduced Discussion: Although structured data is helpful, use of free text in the summary of care document is acceptable. When structured fields are used, they should be based on standards (not all fields need to be completed for each purpose). Summary of care documents contain data relevant to the purpose of the transition (i.e. not all fields need to be completed for each purpose)

Improving population and public health: Registries 10 Transmit Data to Registry to Improve Population and Public Health Menu: EPs/ Menu: EHs Purpose: Electronically transmit data from CEHRT in standardized form (i.e., data elements, structure and transport mechanisms) to one registry Reporting should use one of the following mechanisms: 1.Upload information from EHR to registry using standards c-CDA 2.Leverage national or local networks using federated query technologies Discussion: CEHRT is capable (certification criteria only) of allowing end-user to configure which data will be sent to the registries. Registries are important to population management, but there are concerns that this objective will be difficult to implement. Focus AreaTypeProvider use effortStandards MaturityDevelopment  Population management Primary Care Specialty (selectively) HighEmergingHigh Red: Changes from stage 2 Blue: Newly introduced Bright Red: edits for clarity

Listening Session – Draft Framework April – Date TBD Opportunity for the public to provide feedback on MU3 recommendations Members of the public will register in advance and identify a category for comment Registration information – Name, organization, category, summary of comment Categories – MU3 recommendations - Improving quality of care and safety – MU3 recommendations - Engaging patients and families in their care – MU3 recommendations - Improving care coordination – MU3 recommendations - Improving population and public health – Future of Meaningful Use after stage 3 – Benefits of MU for organizations or quality of care Comments will be limited to 3 minutes Specific times will be identified for each category, limiting the number of comments based upon the time allotted to that category Allow 15 minutes for open comment at the end of the session? 11